[HTML][HTML] Cytokine storm in novel coronavirus disease (COVID-19): expert management considerations
Y Mehta, SB Dixit, KG Zirpe… - Indian journal of critical …, 2020 - ncbi.nlm.nih.gov
Y Mehta, SB Dixit, KG Zirpe, AS Ansari
Indian journal of critical care medicine: peer-reviewed, official …, 2020•ncbi.nlm.nih.govBackground Cytokine storm is caused by the colossal release of proinflammatory cytokines
[eg, IL (interleukin)-2, IL-6, IL-8 TNF (tumor necrosis factor)-α, etc.] causing dysregulated,
hyperimmune response. This immunopathogenesis leads to acute lung injury and acute
respiratory distress syndrome (ARDS). Targeting cytokine storm with the therapies that are
already available in India with the support of published guidelines and consensus can assist
in achieving a better outcome in COVID-19.
[eg, IL (interleukin)-2, IL-6, IL-8 TNF (tumor necrosis factor)-α, etc.] causing dysregulated,
hyperimmune response. This immunopathogenesis leads to acute lung injury and acute
respiratory distress syndrome (ARDS). Targeting cytokine storm with the therapies that are
already available in India with the support of published guidelines and consensus can assist
in achieving a better outcome in COVID-19.
Background
Cytokine storm is caused by the colossal release of proinflammatory cytokines [eg, IL (interleukin)-2, IL-6, IL-8 TNF (tumor necrosis factor)-α, etc.] causing dysregulated, hyperimmune response. This immunopathogenesis leads to acute lung injury and acute respiratory distress syndrome (ARDS). Targeting cytokine storm with the therapies that are already available in India with the support of published guidelines and consensus can assist in achieving a better outcome in COVID-19.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果